A new study reveals a 15 per cent rise in adult ADHD diagnoses between 2020 and 2023, while teenage rates remain stable.

(RTTNews) - French drug major Sanofi (SNY) announced Monday that its Sarclisa has obtained first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma ...

including an increase among adults from 2020 to 2023. The study, published in the journal Psychiatric Research and Clinical Practice, found a significant downward trends in ADHD incidence among ...

If you click on links we provide, we may receive compensation. Decorate with flowers, wall art, and more building kits Clint is a veteran journalist with more than 13 years in digital publishing.